Kai‐Uwe Kern

648 total citations
33 papers, 413 citations indexed

About

Kai‐Uwe Kern is a scholar working on Physiology, Neurology and Pharmacology. According to data from OpenAlex, Kai‐Uwe Kern has authored 33 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 15 papers in Neurology and 14 papers in Pharmacology. Recurrent topics in Kai‐Uwe Kern's work include Pain Mechanisms and Treatments (26 papers), Botulinum Toxin and Related Neurological Disorders (14 papers) and Musculoskeletal pain and rehabilitation (14 papers). Kai‐Uwe Kern is often cited by papers focused on Pain Mechanisms and Treatments (26 papers), Botulinum Toxin and Related Neurological Disorders (14 papers) and Musculoskeletal pain and rehabilitation (14 papers). Kai‐Uwe Kern collaborates with scholars based in Germany, United Kingdom and United States. Kai‐Uwe Kern's co-authors include Ralf Baron, Thomas Weiser, Nanna Brix Finnerup, Robert H. Dworkin, Guy Hans, Gérard Mick, T. Wagner, Michael Schenk, J. Schlaier and Ilona Steigerwald and has published in prestigious journals such as Pain, Headache The Journal of Head and Face Pain and Clinical Therapeutics.

In The Last Decade

Kai‐Uwe Kern

33 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai‐Uwe Kern Germany 12 249 115 107 103 65 33 413
María Pérez Spain 12 174 0.7× 83 0.7× 122 1.1× 55 0.5× 13 0.2× 33 397
P Donofrio Italy 6 333 1.3× 205 1.8× 93 0.9× 147 1.4× 37 0.6× 16 492
E Pichard-Léandri France 6 152 0.6× 46 0.4× 41 0.4× 80 0.8× 26 0.4× 14 462
Ann Kvarnström Sweden 2 198 0.8× 96 0.8× 120 1.1× 71 0.7× 9 0.1× 2 281
Janet Pennella‐Vaughan United States 6 257 1.0× 150 1.3× 126 1.2× 47 0.5× 6 0.1× 6 382
Salah Rahman Germany 6 249 1.0× 65 0.6× 258 2.4× 321 3.1× 37 0.6× 8 445
Jai Won Jung United States 10 54 0.2× 20 0.2× 124 1.2× 58 0.6× 38 0.6× 24 347
Robert Schedel Germany 6 158 0.6× 60 0.5× 94 0.9× 74 0.7× 7 0.1× 7 376
Marcie Fowler United States 13 59 0.2× 16 0.1× 90 0.8× 44 0.4× 26 0.4× 17 511
R. Baron Germany 8 190 0.8× 178 1.5× 95 0.9× 108 1.0× 3 0.0× 12 383

Countries citing papers authored by Kai‐Uwe Kern

Since Specialization
Citations

This map shows the geographic impact of Kai‐Uwe Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Uwe Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Uwe Kern more than expected).

Fields of papers citing papers by Kai‐Uwe Kern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Uwe Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Uwe Kern. The network helps show where Kai‐Uwe Kern may publish in the future.

Co-authorship network of co-authors of Kai‐Uwe Kern

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Uwe Kern. A scholar is included among the top collaborators of Kai‐Uwe Kern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Uwe Kern. Kai‐Uwe Kern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kern, Kai‐Uwe. (2023). Low Back Pain Management in Routine Clinical Practice: What is Important for the Individual Patient?. Pain Management. 13(4). 243–252. 1 indexed citations
3.
Russo, Marc, Ralf Baron, Anthony H. Dickenson, Kai‐Uwe Kern, & Danielle M. Santarelli. (2022). Ambroxol for neuropathic pain: hiding in plain sight?. Pain. 164(1). 3–13. 9 indexed citations
4.
Huygen, Frank, Kai‐Uwe Kern, & Concepción Pérez. (2020). <p>Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain</p>. Journal of Pain Research. Volume 13. 2585–2597. 5 indexed citations
5.
Kraus, M., Nicholas Lintzeris, Arun Bhaskar, et al.. (2019). Consensus and Controversies Between Pain and Addiction Experts on the Prevention, Diagnosis, and Management of Prescription Opioid Use Disorder. Journal of Addiction Medicine. 14(1). 1–11. 36 indexed citations
6.
Kern, Kai‐Uwe, et al.. (2018). Post-Zoster-Neuralgie des linken Trigeminusastes V1. Der Schmerz. 32(6). 464–467. 6 indexed citations
7.
Kern, Kai‐Uwe, et al.. (2017). Ambroxol for the treatment of fibromyalgia: science or fiction?. Journal of Pain Research. Volume 10. 1905–1929. 7 indexed citations
8.
Kern, Kai‐Uwe & Thomas Weiser. (2015). Topical ambroxol for the treatment of neuropathic pain. Der Schmerz. 29(S3). 89–96. 20 indexed citations
9.
Kern, Kai‐Uwe & Thomas Weiser. (2015). Topisches Ambroxol zur Behandlung neuropathischer Schmerzen. Der Schmerz. 29(6). 632–640. 8 indexed citations
10.
Kern, Kai‐Uwe, et al.. (2014). [Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone].. PubMed. 156 Suppl 2. 54–63. 6 indexed citations
11.
Schenk, Michael, et al.. (2014). Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain. Clinical Therapeutics. 37(1). 94–113. 30 indexed citations
12.
Kern, Kai‐Uwe, et al.. (2014). Das 8 %ige Capsaicin-Pflaster bei Phantomschmerz. Der Schmerz. 28(4). 374–383. 8 indexed citations
13.
Kern, Kai‐Uwe, et al.. (2013). Is physician supervision of the capsaicin 8% patch administration procedure really necessary? An opinion from health care professionals. Journal of Pain Research. 6. 571–571. 6 indexed citations
14.
15.
Kern, Kai‐Uwe, Patric Bialas, & Daniela Fangmann. (2013). Retardiertes Tapentadol bei Phantomschmerzen. Der Schmerz. 27(2). 174–181. 4 indexed citations
16.
Kern, Kai‐Uwe, et al.. (2012). Wirkung von Botulinumtoxin Typ B auf Stumpfschwitzen und Stumpfschmerzen. Der Schmerz. 26(2). 176–184. 6 indexed citations
17.
Kern, Kai‐Uwe, J. Schlaier, Ernil Hansen, et al.. (2011). Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy. Journal of Clinical Neuroscience. 19(1). 99–100. 44 indexed citations
18.
Mick, Gérard, Ralf Baron, Nanna Brix Finnerup, et al.. (2011). What is Localized Neuropathic Pain? A First Proposal to Characterize and Define a Widely Used Term. Pain Management. 2(1). 71–77. 55 indexed citations
19.
Kern, Kai‐Uwe, et al.. (2010). Lidocain-Pflaster zur Therapie neuropathischer und nichtneuropathischer Schmerzen. Der Nervenarzt. 81(12). 1490–1497. 7 indexed citations
20.
Kern, Kai‐Uwe, et al.. (2005). Auslösung von Phantomschmerzen und -sensationen durch muskuläre Stumpftriggerpunkte nach Beinamputationen. Der Schmerz. 20(4). 300–306. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026